ÂÜÀòÂÒÂ×

Julianne Berry, Ph.D., currently serves as Vice President of Respiratory Product Development at Odin Pharmaceuticals, LLC, since September 2021, focusing on establishing respiratory programs from early stages to commercialization. Prior to this role, Julianne held the position of Senior Director of Respiratory Research and Development at Glenmark Pharmaceuticals from January 2017, where leadership involved overseeing pharmaceutical R&D teams and advancing global respiratory programs. Julianne's earlier experience includes Senior Principal Scientist at Lupin Pharmaceuticals, managing respiratory and specialty product groups, and Principal Scientist at Merck, where significant contributions included the commercialization of Dulera®. Additionally, Julianne's career began as a Research Fellow at Schering-Plough Research Institute and included a postdoctoral fellowship at the University of Kansas. Julianne completed a Ph.D. in Physical Organic Chemistry at the University of California and a bachelor's degree in Chemistry from Colgate University.